SCYNEXIS, Inc. Revenue from Related Parties
SCYNEXIS, Inc. (SCYX) reported Revenue from Related Parties of $2.14 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-07.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2016-03-07
- SCYNEXIS, Inc. revenue from related parties for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. revenue from related parties for the quarter ending 2015-09-30 was $165.00K, a 90.94% decline year-over-year.
- SCYNEXIS, Inc. revenue from related parties for the quarter ending 2015-06-30 was $988.00K, a 45.77% decline year-over-year.
- SCYNEXIS, Inc. revenue from related parties for the quarter ending 2015-03-31 was $987.00K, a 45.83% decline year-over-year.
- SCYNEXIS, Inc. revenue from related parties for fiscal 2015 was $2.14M, a 70.64% decline from fiscal 2014.
- SCYNEXIS, Inc. revenue from related parties for fiscal 2014 was $7.29M.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $165.00K derived: sum of 2 quarters · filed 2016-03-07 | $1.15M derived: sum of 3 quarters · filed 2016-03-07 | $2.14M 10-K · filed 2016-03-07 |
| 2015-09-30 | $165.00K 10-Q · filed 2015-11-13 | $1.15M derived: sum of 2 quarters · filed 2015-11-13 | $2.14M 10-Q · filed 2015-11-13 | $3.96M derived: sum of 4 quarters · filed 2016-03-07 |
| 2015-06-30 | $988.00K 10-Q · filed 2015-08-19 | $1.98M 10-Q · filed 2015-08-19 | $3.80M derived: sum of 3 quarters · filed 2016-03-07 | $5.62M derived: sum of 4 quarters · filed 2016-03-07 |
| 2015-03-31 | $987.00K 8-K · filed 2015-10-30 | $2.81M derived: sum of 2 quarters · filed 2016-03-07 | $4.63M derived: sum of 3 quarters · filed 2016-03-07 | $6.45M derived: sum of 4 quarters · filed 2016-03-07 |
| 2014-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $3.64M derived: sum of 2 quarters · filed 2016-03-07 | $5.47M derived: sum of 3 quarters · filed 2016-03-07 | $7.29M 10-K · filed 2016-03-07 |
| 2014-09-30 | $1.82M 10-Q · filed 2015-11-13 | $3.64M derived: sum of 2 quarters · filed 2015-11-13 | $5.47M 10-Q · filed 2015-11-13 | $7.29M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $1.82M 10-Q · filed 2015-08-19 | $3.64M 10-Q · filed 2015-08-19 | $5.47M derived: sum of 3 quarters · filed 2015-10-30 | $7.29M derived: sum of 4 quarters · filed 2015-10-30 |
| 2014-03-31 | $1.82M 8-K · filed 2015-10-30 | $3.64M derived: sum of 2 quarters · filed 2015-10-30 | $5.47M derived: sum of 3 quarters · filed 2015-10-30 | $7.29M derived: sum of 4 quarters · filed 2015-10-30 |
| 2013-12-31 | $1.82M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $3.64M derived: sum of 2 quarters · filed 2015-10-30 | $5.47M derived: sum of 3 quarters · filed 2015-10-30 | $7.29M 8-K · filed 2015-10-30 |
| 2013-09-30 | $1.82M 10-Q · filed 2014-11-13 | $3.64M derived: sum of 2 quarters · filed 2014-11-13 | $5.47M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $1.82M 10-Q · filed 2014-08-13 | $3.64M 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $1.82M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |